chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first thing I felt was a bit of a sore throat.  That night I got no sleep.  The next day I felt awful most of the day.  I thought it might be allergies.  On Saturday I felt awful and test for COVID-19 and it was positive.  I started shivering.  My temperature was 102.5 degrees.  I was coughing and coughing stuff up.  I called my doctor office and he called in Molnupiravir and I began taking it the same day.  I started with a weird taste and then I started to lose my taste.  After taking the medication, I started to feel better within a couple days. After testing negative on the 9th, on the 15th I had a rebound and tested positive again.
Patient has experienced increased muscle pain at the site of the injection beginning roughly 3 weeks after the vaccination was received.  Muscle pain/soreness was "normal" for first few days following vaccination on 9/20/2013, and the soreness was almost completely gone until around 10/09/2013.  The patients wife is also experiencing this, however her situation is more severe.  Patient's situation is manageable.  No other contributing factors such as new activities causing soreness.
I received the 1st dose of the Moderna COVID vaccine, and experienced initially just the standard, expected arm pain at the site of the injection. Several days later I first noticed that the area where I had received the injection had developed a flat, pink discoloration/"rash" approximately 5 cm x 3 cm in diameter, with an irregular but rounded border. There was increased warmth just at the pink area. It did not itch. The only reason I'm mentioning it, is because that large pink discoloration and increased warmth at the site of the injection lasted for 12 full days after I received that injection. On Day 13 it has become less pink, but remains warmer than the skin around it. Otherwise no other symptoms.
increase in anxiety to the point of panic attack occurring; Anxiety; Intense abdominal cramping/Abdominal burning/cramps were at an 8 on the pain scale during the worst periods; Abdominal burning/Abdominal burning/cramps were at an 8 on the pain scale during the worst periods; vomiting since the day after the vaccine; Chills; body shakes; periods of chest tightness; shortness of breath; unable to keep food or fluid down; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at Left arm on 25Apr2021 15:15 at first dose, single for COVID-19 immunization in Pharmacy or Drug Store. Medical history included Major depressive disorder, General anxiety disorder and Known allergies to Z-Pak. concomitant medication was none (the patient was not received any medication within 2 weeks of vaccination). Patient was not Pregnant at Time of Vaccination. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported on 26Apr2021 16:45, patient experienced intense abdominal cramping and vomiting since the day after the vaccine. Chills, body shakes, and periods of chest tightness and shortness of breath. patient was unable to keep food or fluid down until she received a prescription for Ondansetron from her doctor. Abdominal burning/cramps were at an 8 on the pain scale during the worst periods. Also an increase in anxiety to the point of panic attack occurring on 28Apr2021. the adverse event result in Doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. treatment received for the adverse event included Ondansetron and Proair inhaler. Outcome of the events was recovering.   Information on Lot/Batch number was available. Additional information has been requested.
no other AE occurred; VARIVAX was administered after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), 1 dose, lot #u039948, expiration date: 16-DEC-2023 (route of administration was not provided). The administered dose of vaccine experienced the temperature excursion of -2.5 degrees Celsius for 5 hours and 6 minutes. There was no previous temperature excursion. No other adverse event (AE) occurred.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2206USA005579: US-009507513-2206USA005697: US-009507513-2206USA005817: US-009507513-2206USA005711:
Information has been received from a consumer who had shingles twice in less than 4 months, who on 05-MAR-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# not reported). Subsequently the consumer developed "red-itching" and pain (site not reported). The consumer then developed a rash over her body with welts. The consumer also experienced extreme pain in muscle and joints of upper arms, groin and thigh area, with a slight fever. The consumer could not raise her legs, climb stairs and had difficulty with walking; could not raise her arms to shower, comb her hair and had difficulty putting on clothes. On 12-MAR-2010 the consumer went to a physician who ordered hydroxyzine HCl 25 mgm tablets, three times a day. At the time of reporting, the patient still had pain. The consumer had an appointment scheduled with the same primary care physician (PCP). The events of difficulty in walking, upper extremity dysfunction and activities of daily living impaired were considered to be disabling. Additional information has been requested.
Systemic: Stroke-Severe, Additional Details: Mom came in to complain about the reaction his son had with the vaccine. Pt had pfizer vaccine on 7/15/2021 around 1pm. Pt had a seizure 2 hours followig the shot. Pt had a VNS device and heart stopped. Pt went into Afib. Pt was not able to admit to hospital due to no beds. Pt's mom is RN and treated him according his physican. Mom already filed a VAREs report. Pt is still suffering from seizures from time to time and currently taken care. Neurologist not recommends the second dose of pfizer vac
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021 at 9:51 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Feb-2021 at 9:51 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 25.27.  Concomitant products were not provided.  On 27-Feb-2021, Excursion time was 09 AM, 11 AM, 12 PM, 1 PM, 2 PM, 3 PM, 4 PM and 5 PM, temperature was 33, 35, 35, 35, 35, 34, 34, and 35 respectively, total doses given for the day was 199, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 27-Feb-2021. 20 vials were sent to clinic. Vaccine BUD date was 26-Mar-2021.  On 27-Feb-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 33, 10 AM: 36, 11 AM: 35, 12 AM: 35, 1PM: 35, 2 PM: 35, 3 PM: 34, 4 PM: 34 and 5 PM: 35.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant medications were not reported. On unknown dates in 2016 (reported as on or after 11-APR-2016), the patients were vaccinated with improperly stored doses of VARIVAX injection , lot # L025210, expiration date 07-JUL-2017, lot # L046887, expiration date 23-NOV-2017 (dose, route and site of administration were not reported). There was no adverse effect reported. Administered doses of VARIVAX experienced the temperature excursion at 10 degrees Fahrenheit for 68 days. Data logger was involved. There were no previous temperature excursions reported. Product quality complaint was not involved. Additional information has been requested.
Headache, Myalgia, NauseaVomiting, Pain/redness/swelling to left arm, Chills, Fatigue Narrative:
This spontaneous report as received from a nurse practitioner refers to a 59 years old female patient with atrial fibrillation and none drug reactions or allergies. The patient was vaccinated with a dose of live ZOSTAVAX, subcutaneous (route, lot number not reported) on 28-DEC-2012. No other co-suspects were reported. Concomitant medications included XARELTO and metoprolol. On 31-DEC-2012, the patient had a deep tissue massage on the entire body. On 01-JAN-2013, the patient developed a rash on the chest, neck, abdomen and wrists. The patient started acyclovir on 03-JAN-2013 as a treatment for adverse event. None laboratory tests were performed. The outcome of rash on the chest, neck, abdomen and wrists was reported as not recovered. The patient sought medical attention, came into the nurse practitioner's office. The relatedness for adverse event was not reported for live ZOSTAVAX. Additional information is not expected.
She did not take the second dose of the Moderna vaccine; Rash; Chills, very bad chills; hives/hives on both sides of neck over the next day or so; Heart racing, heart was racing off an on very intensely; Throat closed up; Bright red rash on the arm and neck which then she said was mostly on the neck on the side of where she had the shot; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives/hives on both sides of neck over the next day or so), PALPITATIONS (Heart racing, heart was racing off an on very intensely), THROAT TIGHTNESS (Throat closed up), RASH ERYTHEMATOUS (Bright red rash on the arm and neck which then she said was mostly on the neck on the side of where she had the shot) and INTENTIONAL DOSE OMISSION (She did not take the second dose of the Moderna vaccine) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 813L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history for patient was reported.  Concomitant products included VITAMIN D NOS, VITAMIN B12 NOS and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced URTICARIA (hives/hives on both sides of neck over the next day or so), PALPITATIONS (Heart racing, heart was racing off an on very intensely), THROAT TIGHTNESS (Throat closed up), RASH ERYTHEMATOUS (Bright red rash on the arm and neck which then she said was mostly on the neck on the side of where she had the shot), RASH (Rash) and CHILLS (Chills, very bad chills). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (She did not take the second dose of the Moderna vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, URTICARIA (hives/hives on both sides of neck over the next day or so), PALPITATIONS (Heart racing, heart was racing off an on very intensely), THROAT TIGHTNESS (Throat closed up), RASH ERYTHEMATOUS (Bright red rash on the arm and neck which then she said was mostly on the neck on the side of where she had the shot), RASH (Rash) and CHILLS (Chills, very bad chills) outcome was unknown and INTENTIONAL DOSE OMISSION (She did not take the second dose of the Moderna vaccine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Patient did not take the second dose of the Moderna vaccine. She received the second dose of J&J vaccine on 04 JUN 2021. Allergist also told her to drink a lot of water. Action taken with mRNA-1273 in response to the event was withdrawn.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow-up information received on 09 JUN 2021 and added relevant concomitant and treatment medications, new events and updated event details.
Face hot; Arm feels heavy; injection site pain/feel sore at the injection site; feeling cold; Headache; Light-headed; Nauseous; This case was reported by a consumer via call center representative and described the occurrence of headache in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th May 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 9th May 2019, less than a day after receiving Shingrix, the patient experienced headache, light headedness, nausea, heaviness in arm, injection site pain and feeling cold. On 10th May 2019, the patient experienced feeling of warmth facial. On an unknown date, the outcome of the headache, light headedness, nausea, feeling of warmth facial and heaviness in arm were not recovered/not resolved and the outcome of the injection site pain and feeling cold were unknown.   It was unknown if the reporter considered the headache, light headedness, nausea, feeling of warmth facial, heaviness in arm, injection site pain and feeling cold to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix vaccine on right arm the day before reporting.  Within 1.5 to 2 hours she started to feel sore at the injection site.   By 5:00 pm she started to feel cold, and light headed.   By 7:00pm that same day she started to feel nauseous, and developed a headache.   The day of reporting, the patient had the same symptoms and 1 day after vaccination, her face was hot.   She also said her arm was sorer than the day before reporting. The reporter did not give consent to follow up. The reporter unable to obtain additional information. The outcome reported for all AES in the structured field of XML is recovering instead of not resolved (outcome uploaded in Argus)
Flu-like symptoms: Low grade fever, aches, chills, nausea. Treated with acetaminophen ongoing..
Local reaction-redness and swelling at site. Parents using TYLENOL and ice for comfort
12/12/09-received H1N1 inj-RA-IM. 12/13/09-pain in right collar bone noted in morning. 12/13/09-10pm-rash on face from bottom of nose to bottom of chin (both sides). 12/14/09-9am- right arm swelling/pain treatment per patient-Benadryl x1/Tylenol at 3pm 12/14.
Severe headache and myalgia less than 1 hour after shot.  Fever 101.0 12 hours after shot.  Treatment in office = Benadryl 50mg by mouth, Tordol 30mg intramuscular.
Low grade fever, lethargy,  muscle aches, chills, sleepy, mild headache; lasted about twenty hours.  No treatment other than sleep.  Symptoms gradually disappeared.
Elevated blood pressure, dizziness, light headedness, headache, tingling in fingers, burning in chest. Pt given oral Benadryl with some reduction in symptoms. Pt discharged in stable condition.
This spontaneous case reported by a consumer, describes the occurrence of headache in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 0071A21A) for COVID-19 immunization. No medical history reported. On Apr 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 23, 2021, patient experienced headache. At the time of the report, headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported/provided.
1st shot had no reactions at all, just sore and tired. 2nd shot is immediate burning. Its two days after it still burns. Have a circle rash at injection site thats a hard feeling and red, still burns. Used benadryl cream to help burning. Arm pit hurts with it. The headache, soreness, heat, and hardness is fine. But its the burning like a sunburn that is very uncomfortable and seems odd. Skin reaction like this wasnt described as a side effect.
Systemic: Allergic: Anaphylaxis-Medium, Systemic: Shakiness-Mild, Systemic: Tachycardia-Medium, Additional Details: temp within normal range, BP 149, 146, then 161. had a fast heartbeat so drink 2 small water bottle and shaking hands a liitle.\r\npharmay monitored her more than 1 hour and 30 minutes. she is ok to go home. (previous event happened on last december d/t epinephrine inj at dental office)
Pt received IPV and MMR in the same arm and ended up with swelling and pain from the shoulder to the elbow on that arm with redness and warmth.
Large red area with warmth and edema to injection site, migraine, nausea, vomiting, elevated heart rate and blood pressure, weakness
This patient had redness, swelling, hot to touch, hard to touch, pain upon movement and erythema. 5 x 4 cm erythema, warmth induration of left shoulder. Treatment with Keflex, warm compresses and Ibuprofen.
Sore throat on 1-30-22; Binax Now Rapid Antigen Test Negative, Sore throat, some congestion, slight cough; 1-31-22; Rapid Test Negative (same brand as above). Congestion, coughing, fatigue, chills 2-1-22; Positive PCR test. Symptoms at their worst from 2-2-22 to 2-5-22 (in bed resting but not bad enough to require ibuprofen/tylenol or other med) Positive Rapid Antigen Test on 2-7-22, continued to follow CDC regulations through Day 10. No medication taken through duration of COVID illness. Minor fatigue comes and goes to present day (almost 4 weeks later) Coughing continues to present day.  Visited Urgent Care on 2-26-22 due to cough worsening. Diagnosed with bronchitis due to COVID-19 virus. Rx for cough syrup, took for 2 days and cough still present but slowly getting better.
Swelling in RT began on 7/26/20, 5 days after vaccine administration. Swelling continue to increase in size. Family called today and swelling was approximately 3inches long by 2-3inches wide across RT. Recommend ice, ibuprofen, watch for signs/symptoms of infection. Follow up PRN. Will hold off on giving booster vaccine.
Mother stated that patient on 2/7/2022 at 8pm was experiencing a very bad headache, felt very hot to touch, dizziness, body chills and shortness of breath.  Mother gave the patient her inhaler of albuterol and ibuprofen for pain and fever.  Mother then took patient to hospital.  At the hospital the medical staff checked the patient urine and did an EKG and results were normal for both exams.  They administered oral medication to patient of ibuprofen for pain due to the continuous headache she was having.  Patient was then discharged from hospital on 2/8/2022 at 5am.
My son / seizures after a DPT shot; This case was reported by a consumer via interactive digital media and described the occurrence of seizure in a male patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the seizure was unknown.   The reporter considered the seizure to be related to DTPa vaccine.  Additional details were provided as follows: The patient was the reporter's son. The age at vaccination was not reported. The patient started having seizures after a DPT shot. The doctor said it was the pertussis part that did it. The reporter further mentioned that after that incident, the patient and the rest of the reporter's kids received only DT shots without the pertussis.
Fever of approximately 101 for four days while alternating Tylenol and Advil. Welt on arm. Body aches and sharp shooting pains. Stomach pain. Chills. Headache.
A RN provided information concerning a student who was vaccinated with a 2nd dose of MMR and a 2nd dose of DT. On 4/21/1999, 2 days, post vax, the student became "ill" and was hospitalized. The pt was dx'd with viral infection.
Redness one day after vaccine administered, itching one week after vaccine administered. One week later developed a cellulitis in the same area.
pt recvd vax;exp tingling pain radiating down the arm & loss of grip;pain cont to radiate up & down the arm from inject site;
Pain in left shoulder radiating down whole arm; swollen lymph nodes; injection given near top of left shoulder. pain X 6 weeks.
The patient has had severe joint pain since receiving the vaccine. He rates the pain at 3/10  when not moving. When up and moving it is hard for him to walk because he is stiff and sore. and it makes it difficult to do those tasks of ADLs.
Fever; Sweating; nose running; sneezing; hot; cold; felt bad; headache; Had chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), CHILLS (Had chills), HEADACHE (headache), PYREXIA (Fever) and HYPERHIDROSIS (Sweating) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Jan-2021, the patient experienced CHILLS (Had chills). On 27-Jan-2021, the patient experienced FEELING ABNORMAL (felt bad) and HEADACHE (headache). On 30-Jan-2021, the patient experienced PYREXIA (Fever), HYPERHIDROSIS (Sweating), RHINORRHOEA (nose running), SNEEZING (sneezing), FEELING HOT (hot) and FEELING COLD (cold). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt bad), CHILLS (Had chills), HEADACHE (headache), PYREXIA (Fever), HYPERHIDROSIS (Sweating), RHINORRHOEA (nose running), SNEEZING (sneezing), FEELING HOT (hot) and FEELING COLD (cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Medical History information was reported.